The European Union could not say when a joint statement on tariffs with the United States would be ready, nor when the White House would issue an executive or ...

AbbVie to invest $195m in US API manufacturing expansion as pharma rushes to boost domestic capacity ahead of expected drug ...

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Novartis AG today and set a price target of CHF95.00. The company’s shares opened today at CHF96.08. Take advantage of TipRanks Premium ...

Stocks: European stocks largely ticked upward, gaining ground on Monday's close, as investors awaited inflation data from the U.S. and expected insight from Germany ...

Novartis (LON:0QLR) (NYSE:NVS) (SIX:NOVN) said its experimental antibody ianalumab, used in combination with eltrombopag, ...

Novartis drew heightened retail chatter on Monday amid reports that Swiss ministers plan to meet this week with top ...

Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...

The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

If approved, Novartis' ianalumab would become the first targeted treatment for patients with Sjögren’s disease.

Roche (RHHBY) and Novartis (NVS) are scheduled to meet with Swiss officials this week amid U.S. tariff threats on pharma ...

European shares ticked lower on Monday, as investors refrained from making big bets ahead of an eventful week packed with ...

The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...